Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thrombosis × Dexmedetomidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 17 Breast Neoplasms 12 Brain Neoplasms 10 Agnosia 6 Neoplasms 5 Thyroid Neoplasms 4 Delirium 4 Stomach Neoplasms 3 Pituitary Neoplasms 3 Lung Neoplasms 3 Emergence Delirium 3 Chronic Pain 3 Urinary Bladder Neoplasms 2 Supratentorial Neoplasms 2 Rectal Neoplasms 2 Pheochromocytoma 2 Pain, Intractable 2 Pain 2 Liver Neoplasms 2 Dexmedetomidine 2 Colorectal Neoplasms 2 Central Nervous System Diseases 2 Abdominal Neoplasms 2 Thrombosis 1 Spinal Cord Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Sleep Deprivation 1 Sigmoid Neoplasms 1 Sedation 1 Sarcoma 1

Interventions

apixaban 4 Heparin, Low-Molecular-Weight 3 Enoxaparin 3 Dalteparin 3 Blood Specimen Collection 3 Warfarin 2 Rivaroxaban 2 Aspirin 2 palbociclib 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 edoxaban 1 X-Rays 1 Ultrasonography 1 Tinzaparin 1 Technetium Tc 99m Sulfur Colloid 1 Standard of Care 1 Simvastatin 1 Saline Solution 1 Physical Therapy Modalities 1 Photons 1 Phlebotomy 1 Paclitaxel 1 Observation 1 Musculoskeletal Manipulations 1 Injections 1 Hydroxyurea 1 Heparin 1 Fondaparinux 1 Docetaxel 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06993740 2025-06-15

DEXFLAP

Dharmais National Cancer Center Hospital

Phase NA Recruiting

Inflammation, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡